Clinical Topics & News

Alcohol as a Risk Factor for Plaque-Type Psoriasis

Author and Disclosure Information

The association between alcohol and the development of plaque-type psoriasis is complex and confusing because many of the initial studies did not control for confounding factors such as tobacco use. This article presents a literature review of the epidemiologic, case-controlled, and clinical studies that examined the relationship between alcohol and plaque-type psoriasis. Early studies showed no correlation between alcohol consumption and plaque-type psoriasis. However, as researchers began to control for confounding factors, study results often illustrated a significant correlation between alcohol use and psoriasis. Some studies suggested a relative risk factor of 8.01, particularly in men. However, the studies did not document an increased risk for plaque-type psoriasis in women who drank alcohol. We recommend that clinicians discourage patients with psoriasis from consuming alcohol, especially during periods of disease exacerbation.


 

Recommended Reading

Successful Treatment of Recalcitrant Palmoplantar Psoriasis With Etanercept
MDedge Dermatology
Should Coal Tar Products Carry Cancer Warnings?
MDedge Dermatology
Deep Venous Thrombosis After High-Dose Intravenous Immunoglobulin in the Treatment of Pemphigus Vulgaris
MDedge Dermatology
Over-the-Counter Topical Skin Products—A Common Component of Skin Disease Management
MDedge Dermatology
Barriers to Biologics [editorial]
MDedge Dermatology
Sequential Therapy Using Cyclosporine and Acitretin for Treatment of Total Body Psoriasis
MDedge Dermatology
Clinical Benefits in Patients With Psoriasis After Efalizumab Therapy: Clinical Trials Versus Practice
MDedge Dermatology
Clobetasol Propionate Lotion in the Treatment of Moderate to Severe Plaque-Type Psoriasis
MDedge Dermatology
Treatment of Recalcitrant Pemphigus Vulgaris With the Tumor Necrosis Factor α Antagonist Etanercept
MDedge Dermatology
Treatment of Severe, Recalcitrant, Major Aphthous Stomatitis With Adalimumab
MDedge Dermatology